Your browser doesn't support javascript.
loading
Efficacy of Allogeneic Hematopoietic Cell Transplantation in Patients With Chronic Phase CML Resistant or Intolerant to Tyrosine Kinase Inhibitors.
Yassine, Farah; Reljic, Tea; Moustafa, Muhamad Alhaj; Iqbal, Madiha; Murthy, Hemant S; Kumar, Ambuj; Kharfan-Dabaja, Mohamed A.
Afiliação
  • Yassine F; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapies Program, Mayo Clinic Florida, Jacksonville, FL, USA.
  • Reljic T; Research Methods and Biostatistics Core, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
  • Moustafa MA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapies Program, Mayo Clinic Florida, Jacksonville, FL, USA.
  • Iqbal M; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapies Program, Mayo Clinic Florida, Jacksonville, FL, USA.
  • Murthy HS; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapies Program, Mayo Clinic Florida, Jacksonville, FL, USA.
  • Kumar A; Research Methods and Biostatistics Core, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
  • Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapies Program, Mayo Clinic Florida, Jacksonville, FL, USA.
Hematol Oncol Stem Cell Ther ; 15(1): 36-43, 2022 Mar 01.
Article em En | MEDLINE | ID: mdl-33789163

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Systematic_reviews Limite: Adult / Child / Humans Idioma: En Revista: Hematol Oncol Stem Cell Ther Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Systematic_reviews Limite: Adult / Child / Humans Idioma: En Revista: Hematol Oncol Stem Cell Ther Ano de publicação: 2022 Tipo de documento: Article